Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Progress of mesenchymal stem cell therapy for neural and retinal diseases.
[Anti-MOG antibody in different types of immune-mediated optic neuritis].
Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
Value of the MoCA Test as a Screening Instrument in Multiple Sclerosis.
2010 McDonald criteria for diagnosing pediatric multiple sclerosis.
Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation.
Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
Further validation of Multiple Sclerosis Walking Scale-12 scores based on spatiotemporal gait parameters.
The T-cell immunoglobulin and mucin domain (Tim) gene family in asthma, allergy, and autoimmunity.
Chondroitin sulfate β-1,4-N-acetylgalactosaminyltransferase-1 (ChGN-1) polymorphism: Association with progression of multiple sclerosis.
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?
A microbial symbiosis factor prevents intestinal inflammatory disease.
Suppression of the lipid peroxidation process in the CNS reduces neurological expression of experimentally induced autoimmune encephalomyelitis.
Psychosocial, Affective, and Behavioral Consequences of Multiple SclerosisTreatment of the "Whole" Patient.
Multiple sclerosis: Month of birth effect in MS-fact or artefact?
Differences in oligoclonal bands and visual evoked potentials in patients with radiologically and clinically isolated syndrome.
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.
The epidemiology and pathophysiology of neurogenic bladder.
Biomechanical disorders of foot in multiple sclerosis.
Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
Diagnostic value of 3D fluid attenuated inversion recovery sequence in multiple sclerosis.
Clinical and pathological features of acute optic neuritis in Chinese patients.
Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study.
Pages
« first
‹ previous
…
258
259
260
261
262
263
264
265
266
…
next ›
last »